The statements regarding oxidative treatments have not been evaluated by the FDA.
Evidence for systemic injectable use is emerging but not yet definitive
Bethel MA, Patel RA, Merrill P, Lokhnygina Y, Buse JB, Mentz RJ, et al
Effective management often requires several therapies, like: Advertisement If you have obesity or overweight, talk to your healthcare provider to see if a GLP-1 agonist is right for you
A 2024 review article highlights how antioxidants, such as glutathione, can break the cycle of inflammation and oxidative stress, thereby helping to prevent long-term damage and immune dysfunction